LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,390 Cr | ₹820 Cr | ₹992 Cr | ₹1,153 Cr | ₹1,136 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹2,390 Cr |
| Mar2024 | ₹820 Cr |
| Mar2023 | ₹992 Cr |
| Mar2022 | ₹1,153 Cr |
| Mar2021 | ₹1,136 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,390 Cr | 191.57 | |
| Mar2024 | ₹820 Cr | -17.38 | |
| Mar2023 | ₹992 Cr | -13.96 | |
| Mar2022 | ₹1,153 Cr | 1.50 | |
| Mar2021 | ₹1,136 Cr | - | |
Compare Total Non-Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹96,339.1 Cr | -0.4% | 3.2% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -0.4% |
3.2% |
-1.6% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses